A study on enhanced intestinal permeability of clarithromycin nanoparticles

Abstract

The main objective of the present study was to determine the permeability of clarithromycin (CLA)-PLGA nanoparticles using single-pass intestinal perfusion technique in rats. Clarithromycin nanoparticles were prepared by nano-precipitation according to the modified quasi emulsion solvent diffusion technique and evaluated for their physicochemical characteristics. Permeability coefficients (P-eff) in anaesthetized rats were determined at 3 different concentrations. Drug solution or suspensions in PBS was perfused through a cannulated jejunal segment and samples were taken from outlet tubing at different time points up to 90 min. Microbiological assay of CLA and phenol red in the samples were analyzed using an agar well diffusion procedure and HPLC method respectively. The average particle size of prepared nanoparticles was 305 +/- 134 nm. The mean P-eff of CLA solution in concentrations of 150, 250 and 400 mu g/mL was found to be 1.20 (+/- 0.32) Chi 10(-3), 9.62 (+/- 0.46) Chi 10(-4), and 1.36 (+/- 0.95) Chi 10(-3) cm/sec, respectively. The corresponding values for the same concentration of nanoparticles were found to be 2.74 (+/- 0.73) Chi 10(-3), 2.45 (+/- 0.88) Chi 10(-3), and 3.68 (+/- 0.46) Chi 10(-3) cm/s, respectively. The two-tailed Student's t-test showed that the intestinal permeability of CLA nanoparticle suspensions in prepared concentrations were significantly increased in comparison with its solution.